Acceptable risks:
In this riveting story of two heroic men who changed government policy on experimental drugs for the dying, Jonathan Kwitny, one of America's foremost investigative journalists, delivers a hard-hitting indictment of the bureaucrats, doctors, scientists, and corporations that trade life for prof...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York u.a.
Poseidon Press
1992
|
| Schlagworte: | |
| Zusammenfassung: | In this riveting story of two heroic men who changed government policy on experimental drugs for the dying, Jonathan Kwitny, one of America's foremost investigative journalists, delivers a hard-hitting indictment of the bureaucrats, doctors, scientists, and corporations that trade life for profit. In 1984, America became uneasily aware of a new disease known as acquired immuno-deficiency syndrome - AIDS. By the time it began to receive national media attention, thousands had already died, and thousands more were infected. But the administration, the National Institutes of Health, the Food and Drug Administration, and the public were unprepared to deal with this mysterious and deadly epidemic. Two men, Jim Corti and Martin Delaney, undertook the fight against the powerful establishment and its outmoded laws and conventions. Corti was a medical nurse; Delaney, a successful corporate consultant Both gay, they began helping their HIV-positive friends to secure promising anti-AIDS drugs. Soon, the two were running a law-defying, worldwide drug smuggling ring, bringing hope and sometimes relief to the desperately ill, all the while fighting the drug companies, teaching hospitals, and government bureaucrats committed to preserving the status quo. In Acceptable Risks, Jonathan Kwitny brilliantly illuminates the complex human issues of Corti and Delaney's courageous guerrilla rebellion to force the government to change its procedures for approving drugs not only for those affected by AIDS, but for all terminally ill patients whose health might be improved by or prolonged by drugs needlessly delayed under federal testing requirements Kwitny shows how the medical community prevents the use of experimental drugs in order to protect research dollars and patents, even at the cost of patients' lives; how officials at the FDA impede or deny the use of drugs to protect their power base; how major pharmaceutical companies manipulate federal policy to protect their profits; and how the media often distort information to support their own biases. Drawing on the extraordinary experiences of Corti and Delaney, crucial FDA hearings and internal policy disputes, and eye-opening, often shocking, interviews with the principal players, Kwitny addresses some of our nation's most serious health care problems and exposes a system that harmed those it intended to help. He also vividly demonstrates what is exemplary about America: two citizens, at considerable risk and sacrifice, can take on a powerful government agency and, against all odds, succeed in changing its present - and future - policies |
| Beschreibung: | 466 S. |
| ISBN: | 0671732447 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV006618581 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 930318s1992 |||| 00||| engod | ||
| 020 | |a 0671732447 |9 0-671-73244-7 | ||
| 035 | |a (OCoLC)25964563 | ||
| 035 | |a (DE-599)BVBBV006618581 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a RA644.A25 | |
| 082 | 0 | |a 174/.2 |2 20 | |
| 100 | 1 | |a Kwitny, Jonathan |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Acceptable risks |c Jonathan Kwitny |
| 264 | 1 | |a New York u.a. |b Poseidon Press |c 1992 | |
| 300 | |a 466 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 520 | 3 | |a In this riveting story of two heroic men who changed government policy on experimental drugs for the dying, Jonathan Kwitny, one of America's foremost investigative journalists, delivers a hard-hitting indictment of the bureaucrats, doctors, scientists, and corporations that trade life for profit. In 1984, America became uneasily aware of a new disease known as acquired immuno-deficiency syndrome - AIDS. By the time it began to receive national media attention, thousands had already died, and thousands more were infected. But the administration, the National Institutes of Health, the Food and Drug Administration, and the public were unprepared to deal with this mysterious and deadly epidemic. Two men, Jim Corti and Martin Delaney, undertook the fight against the powerful establishment and its outmoded laws and conventions. Corti was a medical nurse; Delaney, a successful corporate consultant | |
| 520 | 3 | |a Both gay, they began helping their HIV-positive friends to secure promising anti-AIDS drugs. Soon, the two were running a law-defying, worldwide drug smuggling ring, bringing hope and sometimes relief to the desperately ill, all the while fighting the drug companies, teaching hospitals, and government bureaucrats committed to preserving the status quo. In Acceptable Risks, Jonathan Kwitny brilliantly illuminates the complex human issues of Corti and Delaney's courageous guerrilla rebellion to force the government to change its procedures for approving drugs not only for those affected by AIDS, but for all terminally ill patients whose health might be improved by or prolonged by drugs needlessly delayed under federal testing requirements | |
| 520 | 3 | |a Kwitny shows how the medical community prevents the use of experimental drugs in order to protect research dollars and patents, even at the cost of patients' lives; how officials at the FDA impede or deny the use of drugs to protect their power base; how major pharmaceutical companies manipulate federal policy to protect their profits; and how the media often distort information to support their own biases. Drawing on the extraordinary experiences of Corti and Delaney, crucial FDA hearings and internal policy disputes, and eye-opening, often shocking, interviews with the principal players, Kwitny addresses some of our nation's most serious health care problems and exposes a system that harmed those it intended to help. He also vividly demonstrates what is exemplary about America: two citizens, at considerable risk and sacrifice, can take on a powerful government agency and, against all odds, succeed in changing its present - and future - policies | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a AIDS (Disease) |x Chemotherapy |x Moral and ethical aspects | |
| 650 | 4 | |a AIDS (Disease) |x Patients |x Legal status, laws, etc. |z United States | |
| 650 | 4 | |a Acquired Immunodeficiency Syndrome |x drug therapy |z United States |v Personal Narratives | |
| 650 | 4 | |a Acquired Immunodeficiency Syndrome |x history |z United States |v Personal Narratives | |
| 650 | 4 | |a Drug legalization |z United States | |
| 650 | 4 | |a Drugs, Investigational |x therapeutic use |z United States |v Personal Narratives | |
| 650 | 4 | |a HIV Infections |x drug therapy |z United States |v Personal Narratives | |
| 650 | 4 | |a Pharmaceutical policy |z United States | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Aids |0 (DE-588)4112470-4 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Aids |0 (DE-588)4112470-4 |D s |
| 689 | 0 | 2 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 3 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 4 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Aids |0 (DE-588)4112470-4 |D s |
| 689 | 1 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 1 | 3 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | 4 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004229389 | ||
Datensatz im Suchindex
| _version_ | 1804120894916788224 |
|---|---|
| any_adam_object | |
| author | Kwitny, Jonathan |
| author_facet | Kwitny, Jonathan |
| author_role | aut |
| author_sort | Kwitny, Jonathan |
| author_variant | j k jk |
| building | Verbundindex |
| bvnumber | BV006618581 |
| callnumber-first | R - Medicine |
| callnumber-label | RA644 |
| callnumber-raw | RA644.A25 |
| callnumber-search | RA644.A25 |
| callnumber-sort | RA 3644 A25 |
| callnumber-subject | RA - Public Medicine |
| ctrlnum | (OCoLC)25964563 (DE-599)BVBBV006618581 |
| dewey-full | 174/.2 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174/.2 |
| dewey-search | 174/.2 |
| dewey-sort | 3174 12 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04976nam a2200649 c 4500</leader><controlfield tag="001">BV006618581</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930318s1992 |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0671732447</subfield><subfield code="9">0-671-73244-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25964563</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006618581</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA644.A25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174/.2</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kwitny, Jonathan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Acceptable risks</subfield><subfield code="c">Jonathan Kwitny</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Poseidon Press</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">466 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">In this riveting story of two heroic men who changed government policy on experimental drugs for the dying, Jonathan Kwitny, one of America's foremost investigative journalists, delivers a hard-hitting indictment of the bureaucrats, doctors, scientists, and corporations that trade life for profit. In 1984, America became uneasily aware of a new disease known as acquired immuno-deficiency syndrome - AIDS. By the time it began to receive national media attention, thousands had already died, and thousands more were infected. But the administration, the National Institutes of Health, the Food and Drug Administration, and the public were unprepared to deal with this mysterious and deadly epidemic. Two men, Jim Corti and Martin Delaney, undertook the fight against the powerful establishment and its outmoded laws and conventions. Corti was a medical nurse; Delaney, a successful corporate consultant</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Both gay, they began helping their HIV-positive friends to secure promising anti-AIDS drugs. Soon, the two were running a law-defying, worldwide drug smuggling ring, bringing hope and sometimes relief to the desperately ill, all the while fighting the drug companies, teaching hospitals, and government bureaucrats committed to preserving the status quo. In Acceptable Risks, Jonathan Kwitny brilliantly illuminates the complex human issues of Corti and Delaney's courageous guerrilla rebellion to force the government to change its procedures for approving drugs not only for those affected by AIDS, but for all terminally ill patients whose health might be improved by or prolonged by drugs needlessly delayed under federal testing requirements</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Kwitny shows how the medical community prevents the use of experimental drugs in order to protect research dollars and patents, even at the cost of patients' lives; how officials at the FDA impede or deny the use of drugs to protect their power base; how major pharmaceutical companies manipulate federal policy to protect their profits; and how the media often distort information to support their own biases. Drawing on the extraordinary experiences of Corti and Delaney, crucial FDA hearings and internal policy disputes, and eye-opening, often shocking, interviews with the principal players, Kwitny addresses some of our nation's most serious health care problems and exposes a system that harmed those it intended to help. He also vividly demonstrates what is exemplary about America: two citizens, at considerable risk and sacrifice, can take on a powerful government agency and, against all odds, succeed in changing its present - and future - policies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Moral and ethical aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Patients</subfield><subfield code="x">Legal status, laws, etc.</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acquired Immunodeficiency Syndrome</subfield><subfield code="x">drug therapy</subfield><subfield code="z">United States</subfield><subfield code="v">Personal Narratives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acquired Immunodeficiency Syndrome</subfield><subfield code="x">history</subfield><subfield code="z">United States</subfield><subfield code="v">Personal Narratives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug legalization</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs, Investigational</subfield><subfield code="x">therapeutic use</subfield><subfield code="z">United States</subfield><subfield code="v">Personal Narratives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Infections</subfield><subfield code="x">drug therapy</subfield><subfield code="z">United States</subfield><subfield code="v">Personal Narratives</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004229389</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV006618581 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T16:49:21Z |
| institution | BVB |
| isbn | 0671732447 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004229389 |
| oclc_num | 25964563 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | 466 S. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Poseidon Press |
| record_format | marc |
| spelling | Kwitny, Jonathan Verfasser aut Acceptable risks Jonathan Kwitny New York u.a. Poseidon Press 1992 466 S. txt rdacontent n rdamedia nc rdacarrier In this riveting story of two heroic men who changed government policy on experimental drugs for the dying, Jonathan Kwitny, one of America's foremost investigative journalists, delivers a hard-hitting indictment of the bureaucrats, doctors, scientists, and corporations that trade life for profit. In 1984, America became uneasily aware of a new disease known as acquired immuno-deficiency syndrome - AIDS. By the time it began to receive national media attention, thousands had already died, and thousands more were infected. But the administration, the National Institutes of Health, the Food and Drug Administration, and the public were unprepared to deal with this mysterious and deadly epidemic. Two men, Jim Corti and Martin Delaney, undertook the fight against the powerful establishment and its outmoded laws and conventions. Corti was a medical nurse; Delaney, a successful corporate consultant Both gay, they began helping their HIV-positive friends to secure promising anti-AIDS drugs. Soon, the two were running a law-defying, worldwide drug smuggling ring, bringing hope and sometimes relief to the desperately ill, all the while fighting the drug companies, teaching hospitals, and government bureaucrats committed to preserving the status quo. In Acceptable Risks, Jonathan Kwitny brilliantly illuminates the complex human issues of Corti and Delaney's courageous guerrilla rebellion to force the government to change its procedures for approving drugs not only for those affected by AIDS, but for all terminally ill patients whose health might be improved by or prolonged by drugs needlessly delayed under federal testing requirements Kwitny shows how the medical community prevents the use of experimental drugs in order to protect research dollars and patents, even at the cost of patients' lives; how officials at the FDA impede or deny the use of drugs to protect their power base; how major pharmaceutical companies manipulate federal policy to protect their profits; and how the media often distort information to support their own biases. Drawing on the extraordinary experiences of Corti and Delaney, crucial FDA hearings and internal policy disputes, and eye-opening, often shocking, interviews with the principal players, Kwitny addresses some of our nation's most serious health care problems and exposes a system that harmed those it intended to help. He also vividly demonstrates what is exemplary about America: two citizens, at considerable risk and sacrifice, can take on a powerful government agency and, against all odds, succeed in changing its present - and future - policies Ethik AIDS (Disease) Chemotherapy Moral and ethical aspects AIDS (Disease) Patients Legal status, laws, etc. United States Acquired Immunodeficiency Syndrome drug therapy United States Personal Narratives Acquired Immunodeficiency Syndrome history United States Personal Narratives Drug legalization United States Drugs, Investigational therapeutic use United States Personal Narratives HIV Infections drug therapy United States Personal Narratives Pharmaceutical policy United States Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Aids (DE-588)4112470-4 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Aids (DE-588)4112470-4 s Pharmazeutische Industrie (DE-588)4045696-1 s Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s DE-604 Gesundheitspolitik (DE-588)4113743-7 s |
| spellingShingle | Kwitny, Jonathan Acceptable risks Ethik AIDS (Disease) Chemotherapy Moral and ethical aspects AIDS (Disease) Patients Legal status, laws, etc. United States Acquired Immunodeficiency Syndrome drug therapy United States Personal Narratives Acquired Immunodeficiency Syndrome history United States Personal Narratives Drug legalization United States Drugs, Investigational therapeutic use United States Personal Narratives HIV Infections drug therapy United States Personal Narratives Pharmaceutical policy United States Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd Aids (DE-588)4112470-4 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4113743-7 (DE-588)4127410-6 (DE-588)4003115-9 (DE-588)4112470-4 (DE-588)4078704-7 |
| title | Acceptable risks |
| title_auth | Acceptable risks |
| title_exact_search | Acceptable risks |
| title_full | Acceptable risks Jonathan Kwitny |
| title_fullStr | Acceptable risks Jonathan Kwitny |
| title_full_unstemmed | Acceptable risks Jonathan Kwitny |
| title_short | Acceptable risks |
| title_sort | acceptable risks |
| topic | Ethik AIDS (Disease) Chemotherapy Moral and ethical aspects AIDS (Disease) Patients Legal status, laws, etc. United States Acquired Immunodeficiency Syndrome drug therapy United States Personal Narratives Acquired Immunodeficiency Syndrome history United States Personal Narratives Drug legalization United States Drugs, Investigational therapeutic use United States Personal Narratives HIV Infections drug therapy United States Personal Narratives Pharmaceutical policy United States Pharmazeutische Industrie (DE-588)4045696-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd Aids (DE-588)4112470-4 gnd |
| topic_facet | Ethik AIDS (Disease) Chemotherapy Moral and ethical aspects AIDS (Disease) Patients Legal status, laws, etc. United States Acquired Immunodeficiency Syndrome drug therapy United States Personal Narratives Acquired Immunodeficiency Syndrome history United States Personal Narratives Drug legalization United States Drugs, Investigational therapeutic use United States Personal Narratives HIV Infections drug therapy United States Personal Narratives Pharmaceutical policy United States Pharmazeutische Industrie Gesundheitspolitik Zulassung Arzneimittel Aids USA |
| work_keys_str_mv | AT kwitnyjonathan acceptablerisks |